L499-0751 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]benzamide

L499-0751 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]benzamide
L499-0751 Screening compound: N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L499-0751
N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L499-0751

Molecular Formula

C28H28FN5O2 (C28 H28 FN5 O2)

Compound Name

N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]benzamide

IUPAC name

N-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-3-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]benzamide

SMILES

CCN1CCN(Cc(cc2)ccc2NC(c2cccc(-c3nc(-c(cc4)ccc4F)no3)c2)=O)CC1

InChI

InChI=1S/C28H28FN5O2/c1-2-33-14-16-34(17-15-33)19-20-6-12-25(13-7-20)30-27(35)22-4-3-5-23(18-22)28-31-26(32-36-28)21-8-10-24(29)11-9-21/h3-13,18H,2,14-17,19H2,1H3,(H,30,35)

InChI Key

IXPFTSGITADDEM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27458354

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.653

Distribution Coefficient, logD

3.721

Water Solubility, LogSw

-4.36

Polar Surface Area

62.005

Acid Dissociation Constant (pKa)

11.02

Base Dissociation Constant (pKb)

8.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

L499-0751 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L499-0751 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L499-0751?
Check Price and Availability of L499-0751, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L499-0751 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L499-0751
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L499-0751
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L499-0751 available by request